I. Gonzalez et al., FLUOROQUINOLONE RESISTANCE MUTATIONS IN THE PARC, PARE, AND GYRA GENES OF CLINICAL ISOLATES OF VIRIDANS GROUP STREPTOCOCCI, Antimicrobial agents and chemotherapy, 42(11), 1998, pp. 2792-2798
The nucleotide sequences of the quinolone resistance-determining regio
ns (QRDRs) of the parC and gyrA genes from seven ciprofloxacin-resista
nt (Cp-r) isolates of viridans group streptococci (two high-level Cp-r
Streptococcus oralis and five low-level Cp-r Streptococcus mitis isol
ates) were determined and compared with those obtained from susceptibl
e isolates. The nucleotide sequences of the QRDRs of the parE and gyrB
genes from the five low-level Cp-r S. mitis isolates and from the NCT
C 12261 type strain were also analyzed. Four of these low-level Cp-r i
solates had changes affecting the subunits of DNA topoisomerase IV: th
ree in Ser-79 (to Phe or Ile) of ParC and one in ParE at a position no
t previously described to be involved in quinolone resistance (Pro-424
). One isolate did not show any mutation. The two high-level Cp-r S. o
ralis isolates showed mutations affecting equivalent residue positions
of ParC and GyrA, namely, Ser-79 to Phe and Ser-81 to Phe or Yyr, res
pectively. The parC mutations were able to transform Streptococcus pne
umoniae to ciprofloxacin resistance, while the gyrA mutations transfor
med S. pneumoniae only when mutations in parC were present. These resu
lts suggest that DNA topoisomerase IV is a primary target of ciproflox
acin in viridans group streptococci, DNA gyrase being a secondary targ
et.